866-997-4948(US-Canada Toll Free)

Breast Cancer - Pipeline Review, 2015

Published By :

GlobalData

Published Date : Oct 2015

Category :

Cancer

No. of Pages : 352 Pages

Breast Cancer - Pipeline Review, 2015

Summary

GlobalData's Medical Devices sector report, Breast Cancer - Pipeline Review, 2015" provides an overview of Breast Cancer diagnostic tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Breast Cancer diagnostic tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Breast Cancer diagnostic tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Breast Cancer diagnostic tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Breast Cancer diagnostic tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 21
2 Introduction 22
2.1 Breast Cancer Overview 22
3 Products under Development 23
3.1 Breast Cancer - Pipeline Products by Stage of Development 23
3.2 Breast Cancer - Pipeline Products by Territory 24
3.3 Breast Cancer - Pipeline Products by Regulatory Path 25
3.4 Breast Cancer - Pipeline Products by Estimated Approval Date 26
3.5 Breast Cancer - Ongoing Clinical Trials 27
4 Breast Cancer - Pipeline Products under Development by Companies 28
4.1 Breast Cancer Companies - Pipeline Products by Stage of Development 28
4.2 Breast Cancer - Pipeline Products by Stage of Development 35
5 Breast Cancer Companies and Product Overview 42
5.1 A&G Pharmaceutical, Inc. Company Overview 42
5.2 Abbott Diagnostics Company Overview 45
5.3 Abcodia Ltd. Company Overview 56
5.4 Abviva, Inc. Company Overview 57
5.5 Accelerated Medical Diagnostics Company Overview 58
5.6 Acobiom Company Overview 59
5.7 Advanced Cell Diagnostics, Inc. Company Overview 60
5.8 Affichem SA Company Overview 61
5.9 AIT Austrian Institute of Technology GmbH Company Overview 62
5.10 Almac Diagnostics Limited Company Overview 63
5.11 Amarantus Bioscience Holdings, Inc. Company Overview 64
5.12 AngioGenex, Inc. Company Overview 66
5.13 Armune BioScience, Inc. Company Overview 72
5.14 Arno Therapeutics, Inc. Company Overview 73
5.15 AroCell AB Company Overview 76
5.16 ArtemixRx Company Overview 77
5.17 Ascendant Diagnostics, LLC Company Overview 78
5.18 Assurance Biosciences, Inc. Company Overview 79
5.19 Atossa Genetics, Inc. Company Overview 80
5.20 Aurelium BioPharma Inc. (Inactive) Company Overview 85
5.21 Autoimmune Technologies, LLC Company Overview 87
5.22 Ayanda Biosystems S.A. Company Overview 88
5.23 Becton, Dickinson and Company Company Overview 89
5.24 Bio Gene Ltd. Company Overview 91
5.25 BioAffinity Technologies, Inc. Company Overview 92
5.26 Biocrates Life Sciences AG Company Overview 93
5.27 Biodesix Inc. Company Overview 94
5.28 BioMarCare Technologies Ltd. Company Overview 95
5.29 BioMark Diagnostics Inc. Company Overview 97
5.30 BioMark Technologies Inc. Company Overview 98
5.31 BioMarker Strategies, LLC Company Overview 99
5.32 bioMerieux S.A. Company Overview 100
5.33 Biosceptre (Aust) Pty Ltd Company Overview 102
5.34 BioSystems International Company Overview 103
5.35 bioTheranostics, Inc. Company Overview 104
5.36 Boston College Company Overview 107
5.37 Candiag LLC. Company Overview 108
5.38 Caprion Inc. Company Overview 109
5.39 Cellanyx Diagnostics, Inc. Company Overview 110
5.40 CellXplore, Inc. Company Overview 111
5.41 Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco Company Overview 112
5.42 Cepheid Company Overview 113
5.43 Ceres Nanosciences, Inc. Company Overview 117
5.44 Cernostics Inc. Company Overview 118
5.45 China Sky One Medical, Inc. Company Overview 119
5.46 Chronix Biomedical, Inc. Company Overview 120
5.47 Clarient, Inc. Company Overview 121
5.48 Cleveland Diagnostics Inc. Company Overview 122
5.49 Clovis Oncology, Inc. Company Overview 123
5.50 CompanDX Ltd. Company Overview 125
5.51 Courtagen Life Sciences, Inc. Company Overview 126
5.52 CS-Keys, Inc. Company Overview 127
5.53 Da An Gene Co., Ltd. Company Overview 128
5.54 Dana-Farber Cancer Institute, Inc. Company Overview 130
5.55 Dartmouth College Company Overview 132
5.56 diaDexus, Inc. Company Overview 134
5.57 Diaxonhit S.A. Company Overview 136
5.58 Dublin City University Company Overview 140
5.59 Eventus Diagnostics, Inc. Company Overview 141
5.60 Exiqon A/S Company Overview 145
5.61 Exosomics Siena SpA Company Overview 147
5.62 Fermiscan Holdings Limited Company Overview 148
5.63 Fina Biotech Company Overview 152
5.64 Fluxion Biosciences, Inc. Company Overview 153
5.65 Fournira Optime Diagnostics Company Overview 154
5.66 GeneAssess, Inc. Company Overview 155
5.67 GeneFluidics Inc. Company Overview 156
5.68 GeneNews Limited Company Overview 157
5.69 GenomicTree, Inc. Company Overview 159
5.70 George Washington University Company Overview 160
5.71 German Cancer Research Center Company Overview 161
5.72 Ghent University Company Overview 164
5.73 GILUPI Nanomedizin Company Overview 165
5.74 GlycoZym Company Overview 166
5.75 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 167
5.76 Hai Kang Life Corporation Limited Company Overview 168
5.77 Health Discovery Corporation Company Overview 169
5.78 Hebrew University of Jerusalem Company Overview 170
5.79 Heragen, Inc. Company Overview 171
5.80 HistoRx, Inc. (Inactive) Company Overview 172
5.81 HTG Molecular Diagnostics, Inc. Company Overview 174
5.82 Ikonisys, Inc. Company Overview 176
5.83 IncellDx, Inc. Company Overview 177
5.84 Innovative Health Diagnostics Company Overview 178
5.85 Insight Genetics, Inc. Company Overview 179
5.86 Institut National de la Sante et de la Recherche Medicale Company Overview 181
5.87 IRIS International, Inc. Company Overview 184
5.88 IV Diagnostics, Inc. Company Overview 185
5.89 Iverson Genetic Diagnostics, Inc. Company Overview 186
5.90 Jonakee Cancer Research, Inc. Company Overview 187
5.91 Kalgene Pharmaceuticals Inc. Company Overview 188
5.92 KIYATEC Inc. Company Overview 189
5.93 Leica Biosystems GmbH Company Overview 190
5.94 Louisville Bioscience, Inc. Company Overview 191
5.95 MabCure Inc. Company Overview 192
5.96 Matritech, Inc. (Inactive) Company Overview 193
5.97 Matrix-Bio, Inc. Company Overview 194
5.98 MDNA Life Sciences, Inc. Company Overview 197
5.99 MDxHealth SA Company Overview 198
5.100 MEDITE Cancer Diagnostics, Inc. Company Overview 200
5.101 MedMira Inc. Company Overview 202
5.102 Metabolomic Technologies Inc. Company Overview 204
5.103 MetaStat, Inc. Company Overview 205
5.104 Milagen, Inc. Company Overview 208
5.105 MiRXES Pte Ltd Company Overview 209
5.106 National University of Ireland, Galway Company Overview 210
5.107 Neogenix Oncology, Inc. Company Overview 211
5.108 NeoMatrix, LLC (Inactive) Company Overview 212
5.109 Novel Bio-spectrum Technologies, Inc. Company Overview 213
5.110 Nuclea Biotechnologies Inc. Company Overview 214
5.111 Nuvera Biosciences, Inc. Company Overview 217
5.112 Olink AB Company Overview 222
5.113 Onconome, Inc. Company Overview 224
5.114 OncoStem Diagnostics Pvt. Ltd Company Overview 226
5.115 OncoVista Innovative Therapies, Inc. Company Overview 227
5.116 On-Q-ity, Inc. (Inactive) Company Overview 229
5.117 Orion Genomics LLC Company Overview 230
5.118 OTraces Inc. Company Overview 232
5.119 Panacea Pharmaceuticals, Inc. Company Overview 233
5.120 PeriRx LLC Company Overview 234
5.121 Power3 Medical Products, Inc. Company Overview 235
5.122 PreMD Inc. Company Overview 237
5.123 Proplex Technologies, Llc Company Overview 238
5.124 Protagen AG Company Overview 239
5.125 Proteome Sciences Plc Company Overview 240
5.126 Proteomika Company Overview 242
5.127 Provista Diagnostics Inc. Company Overview 243
5.128 Qiagen N.V. Company Overview 245
5.129 Quest Diagnostics Incorporated Company Overview 247
5.130 Rna Diagnostics Inc. Company Overview 250
5.131 Roche Diagnostics International Ltd. Company Overview 251
5.132 Rosetta Genomics, Ltd. Company Overview 255
5.133 Savicell Diagnostic Ltd. Company Overview 257
5.134 Selventa Company Overview 258
5.135 Sengenics International Pte Ltd Company Overview 259
5.136 Siamab Therapeutics, Inc. Company Overview 260
5.137 Siemens Healthcare Diagnostics Inc. Company Overview 261
5.138 Sividon Diagnostics GmbH Company Overview 263
5.139 Soricimed Biopharma Inc. Company Overview 264
5.140 Target Discovery, Inc. Company Overview 266
5.141 Taxor Diagnostics, LLC Company Overview 267
5.142 The Johns Hopkins University Company Overview 268
5.143 Todos Medical Company Overview 272
5.144 Trinity College Dublin Company Overview 274
5.145 University of Alberta Company Overview 275
5.146 University of California, San Diego Company Overview 276
5.147 University of Chicago Company Overview 277
5.148 University of Colorado Company Overview 278
5.149 University of Maryland, Baltimore Company Overview 280
5.150 University of Nebraska Company Overview 281
5.151 University of Oxford Company Overview 282
5.152 University of South Florida Company Overview 283
5.153 University of Wisconsin Madison Company Overview 284
5.154 US Biomarkers, Inc. Company Overview 285
5.155 Vermillion, Inc. Company Overview 286
5.156 Viomics Inc. Company Overview 289
5.157 Vitatex Inc. Company Overview 290
5.158 Vitruvian Biomedical, Inc. Company Overview 292
5.159 VolitionRX Ltd. Company Overview 293
5.160 XEPTAGEN SpA Company Overview 296
5.161 Xiamen Zeesan Biotech Co.,Ltd Company Overview 298
5.162 Zetiq Technologies Ltd. Company Overview 299
6 Breast Cancer- Recent Developments 300
7 Appendix 346
7.1 Methodology 346
7.2 About GlobalData 348
7.3 Contact Us 349
7.4 Disclaimer 349

1.1 List of Tables
Table 1: Breast Cancer - Pipeline Products by Stage of Development 26
Table 2: Breast Cancer - Pipeline Products by Territory 27
Table 3: Breast Cancer - Pipeline Products by Regulatory Path 28
Table 4: Breast Cancer - Pipeline Products by Estimated Approval Date 29
Table 5: Breast Cancer - Ongoing Clinical Trials 30
Table 6: Breast Cancer Companies - Pipeline Products by Stage of Development 31
Table 7: Breast Cancer - Pipeline Products by Stage of Development 38
Table 8: A&G Pharmaceutical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
Table 9: Onco 88 - Breast Cancer - Product Status 46
Table 10: Onco 88 - Breast Cancer - Product Description 46
Table 11: OncoStain 88 - Breast Cancer - Product Status 47
Table 12: OncoStain 88 - Breast Cancer - Product Description 47
Table 13: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 48
Table 14: CKS1B Companion Diagnostic Assay - Breast Cancer - Product Status 49
Table 15: CKS1B Companion Diagnostic Assay - Breast Cancer - Product Description 49
Table 16: cMET Companion Diagnostic Assay - Breast Cancer - Product Status 50
Table 17: cMET Companion Diagnostic Assay - Breast Cancer - Product Description 50
Table 18: FGFR1 Companion Diagnostic Assay - Breast Cancer - Product Status 51
Table 19: FGFR1 Companion Diagnostic Assay - Breast Cancer - Product Description 51
Table 20: FGFR2 Companion Diagnostic Assay - Breast Cancer - Product Status 52
Table 21: FGFR2 Companion Diagnostic Assay - Breast Cancer - Product Description 52
Table 22: HER2 Companion Diagnostic Assay - Breast Cancer - Product Status 53
Table 23: HER2 Companion Diagnostic Assay - Breast Cancer - Product Description 53
Table 24: IGF1R Companion Diagnostic Assay - Breast Cancer - Product Status 54
Table 25: IGF1R Companion Diagnostic Assay - Breast Cancer - Product Description 54
Table 26: PIK3CA Companion Diagnostic Assay - Breast Cancer - Product Status 55
Table 27: PIK3CA Companion Diagnostic Assay - Breast Cancer - Product Description 55
Table 28: PTEN Companion Diagnostic Assay - Breast Cancer - Product Status 56
Table 29: PTEN Companion Diagnostic Assay - Breast Cancer - Product Description 56
Table 30: TOP2A Companion Diagnostic Assay - Breast Cancer - Product Status 57
Table 31: TOP2A Companion Diagnostic Assay - Breast Cancer - Product Description 57
Table 32: ZNF217 Companion Diagnostic Assay - Breast Cancer - Product Status 58
Table 33: ZNF217 Companion Diagnostic Assay - Breast Cancer - Product Description 58
Table 34: Abcodia Ltd. Pipeline Products & Ongoing Clinical Trials Overview 59
Table 35: Molecular Biomarker - Breast Cancer - Product Status 59
Table 36: Molecular Biomarker - Breast Cancer - Product Description 59
Table 37: Abviva, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
Table 38: Diagnostic Assay - Mammastatin - Product Status 60
Table 39: Diagnostic Assay - Mammastatin - Product Description 60
Table 40: Accelerated Medical Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 61
Table 41: Companion Diagnostic Test - Oxaliplatin - Product Status 61
Table 42: Companion Diagnostic Test - Oxaliplatin - Product Description 61
Table 43: Acobiom Pipeline Products & Ongoing Clinical Trials Overview 62
Table 44: Companion Diagnostic Test - Triple Negative Breast Cancer - Product Status 62
Table 45: Companion Diagnostic Test - Triple Negative Breast Cancer - Product Description 62
Table 46: Advanced Cell Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
Table 47: RNAscope HER2 - Product Status 63
Table 48: RNAscope HER2 - Product Description 63
Table 49: Affichem SA Pipeline Products & Ongoing Clinical Trials Overview 64
Table 50: AF300 Based Enzymatic Immunoassay Kit - Product Status 64
Table 51: AF300 Based Enzymatic Immunoassay Kit - Product Description 64
Table 52: AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 65
Table 53: Diagnostic Assay - Cancer - Product Status 65
Table 54: Diagnostic Assay - Cancer - Product Description 65
Table 55: Almac Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 66
Table 56: Diagnostic Test - Breast Cancer - Product Status 66
Table 57: Diagnostic Test - Breast Cancer - Product Description 66
Table 58: Amarantus Bioscience Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
Table 59: NuroPro - Breast Cancer - Product Status 68
Table 60: NuroPro - Breast Cancer - Product Description 68
Table 61: AngioGenex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69
Table 62: Diagnostic/Prognostic/Surrogate Marker Test - Breast Cancer - Product Status 70
Table 63: Diagnostic/Prognostic/Surrogate Marker Test - Breast Cancer - Product Description 70
Table 64: Id1 Surrogate Marker Diagnostic Or Prognostic Test - Product Status 71
Table 65: Id1 Surrogate Marker Diagnostic Or Prognostic Test - Product Description 71
Table 66: Id2 Surrogate Marker Diagnostic Or Prognostic Test - Product Status 72
Table 67: Id2 Surrogate Marker Diagnostic Or Prognostic Test - Product Description 72
Table 68: Id3 Surrogate Marker Diagnostic or Prognostic Test - Product Status 73
Table 69: Id3 Surrogate Marker Diagnostic or Prognostic Test - Product Description 73
Table 70: Id4 Surrogate Marker Diagnostic Or Prognostic Test - Product Status 74
Table 71: Id4 Surrogate Marker Diagnostic Or Prognostic Test - Product Description 74
Table 72: Armune BioScience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
Table 73: Diagnostic Test - Breast Cancer - Product Status 75
Table 74: Diagnostic Test - Breast Cancer - Product Description 75
Table 75: Arno Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
Table 76: Activated Estrogen Receptor Biomarker Assay - Product Status 77
Table 77: Activated Estrogen Receptor Biomarker Assay - Product Description 77
Table 78: Onapristone Companion Diagnostic Assay - Breast Cancer - Product Status 78
Table 79: Onapristone Companion Diagnostic Assay - Breast Cancer - Product Description 78
Table 80: AroCell AB Pipeline Products & Ongoing Clinical Trials Overview 79
Table 81: TK 210 Assay - Breast Cancer - Product Status 79
Table 82: TK 210 Assay - Breast Cancer - Product Description 79
Table 83: ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview 80
Table 84: ArtemixRx Prognostic Test - Breast Cancer - Product Status 80
Table 85: ArtemixRx Prognostic Test - Breast Cancer - Product Description 80
Table 86: Ascendant Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview 81
Table 87: MelodyDX - Product Status 81
Table 88: MelodyDX - Product Description 81
Table 89: Assurance Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
Table 90: Salivary-Based Assay - Breast Cancer - Product Status 82
Table 91: Salivary-Based Assay - Breast Cancer - Product Description 82
Table 92: Atossa Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
Table 93: ArgusCYTE CTC Test - Product Status 84
Table 94: ArgusCYTE CTC Test - Product Description 84
Table 95: Companion Diagnostic Test - Breast Cancer - Product Status 85
Table 96: Companion Diagnostic Test - Breast Cancer - Product Description 85
Table 97: Next Generation MASCT System - Product Status 86
Table 98: Next Generation MASCT System - Product Description 86
Table 99: NextCYTE Lymph Node Predictor Test - Product Status 87
Table 100: NextCYTE Lymph Node Predictor Test - Product Description 87
Table 101: Aurelium BioPharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 88
Table 102: Breast Cancer Screening Test - Product Status 88
Table 103: Breast Cancer Screening Test - Product Description 88
Table 104: MMD ELISA Test - Breast Cancer - Product Status 89
Table 105: MMD ELISA Test - Breast Cancer - Product Description 89
Table 106: Autoimmune Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 90
Table 107: Diagnostic Assay - Breast Cancer - Product Status 90
Table 108: Diagnostic Assay - Breast Cancer - Product Description 90
Table 109: Ayanda Biosystems S.A. Pipeline Products & Ongoing Clinical Trials Overview 91
Table 110: Diagnostic Test - Breast Cancer - Product Status 91
Table 111: Diagnostic Test - Breast Cancer - Product Description 91
Table 112: Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview 92
Table 113: Diagnostic Test - Breast Cancer - Product Status 93
Table 114: Diagnostic Test - Breast Cancer - Product Description 93
Table 115: Bio Gene Ltd. Pipeline Products & Ongoing Clinical Trials Overview 94
Table 116: Diagnostic Test - Breast Cancer - Product Status 94
Table 117: Diagnostic Test - Breast Cancer - Product Description 94
Table 118: BioAffinity Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
Table 119: CyPath Diagnostic Assay - Breast Cancer - Product Status 95
Table 120: CyPath Diagnostic Assay - Breast Cancer - Product Description 95
Table 121: Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview 96
Table 122: Metabolomic Biomarker Assay - Breast Cancer - Product Status 96
Table 123: Metabolomic Biomarker Assay - Breast Cancer - Product Description 96
Table 124: Biodesix Inc. Pipeline Products & Ongoing Clinical Trials Overview 97
Table 125: VeriStrat - Breast Cancer - Product Status 97
Table 126: VeriStrat - Breast Cancer - Product Description 97
Table 127: BioMarCare Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 98

1.2 List of Figures
Figure 1: Breast Cancer - Pipeline Products by Stage of Development 26
Figure 2: Breast Cancer - Pipeline Products by Territory 27
Figure 3: Breast Cancer - Pipeline Products by Regulatory Path 28
Figure 4: Breast Cancer - Pipeline Products by Estimated Approval Date 29
Figure 5: Breast Cancer - Ongoing Clinical Trials 30

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *